CV Sciences (CVSI) Other Accumulated Expenses (2013 - 2026)
CV Sciences (CVSI) posted Other Accumulated Expenses of $1.1 million for Q1 2026, up 1.76% sequentially from $1.1 million in Q4 2025, and down 24.9% YoY from $1.5 million in Q1 2025.
CV Sciences (CVSI) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
CV Sciences has reported Other Accumulated Expenses for 11 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Other Accumulated Expenses fell 24.9% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 24.9% YoY) and the FY2025 annual result came in at $1.1 million, down 23.96% from the prior year.
- Other Accumulated Expenses grew to $1.1 million in Q1 2026 per CVSI's latest filing, from $1.1 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $1.6 million in Q2 2025 and troughed at $1.1 million in Q4 2025.
- A 5-year average of $1.4 million and a median of $1.5 million in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses gained 6.85% in 2025, then declined 24.9% in 2026.
- Over 5 years, Other Accumulated Expenses stood at $1.5 million in 2022, then retreated by 2.39% to $1.5 million in 2023, then retreated by 5.89% to $1.4 million in 2024, then fell by 23.96% to $1.1 million in 2025, then gained by 1.76% to $1.1 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1.1 million, $1.1 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2018 | 900,555.00 |
| Jun 30, 2018 | 1.11 Mn |
| Mar 31, 2018 | 534,627.00 |
| Dec 31, 2017 | 894,798.00 |
| Sep 30, 2017 | 232,622.00 |
| Jun 30, 2017 | 278,207.00 |
| Mar 31, 2017 | 2.43 Mn |
| Dec 31, 2016 | 170,092.00 |